Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

AOLS

Aeolus Pharmaceuticals Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

AOLS:Aeolus Pharmaceuticals Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.00

EXCHANGE

OTCBB

SECTOR

Health Care

AOLS
Aeolus Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
AOLS
Aeolus Pharmaceuticals Inc Stock Information
Latest Close Price$0.00
52-Week Low/High$0.00 - $0.08
Percent Held by Institutions0.04%
Revenue$784,000
Net Income$-5,043,000
Cash Flow$-578,000
EPS-0.01%
Market Cap$167,295
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-98.59%
Total Return Last 3 Years-99.58%
Total Return Last 5 Years-99.57%
Latest Trade DateDec. 12, 2018
AOLS
Aeolus Pharmaceuticals Inc Dividend Payment History

No Data available for Payment History.

AOLS
Aeolus Pharmaceuticals Inc Other Details

Aeolus Pharmaceuticals is a biopharmaceutical company developing a platform of compounds in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Co.'s primary compound, AEOL 10150 (10150), is being developed under contract as a medical countermeasure against the pulmonary sub-syndrome of acute radiation syndrome and the delayed effects of acute radiation exposure. Co. develops 10150 for the treatment of lung fibrosis, including idiopathic pulmonary fibrosis and other fibrotic disease as well as for use in combination with radiation therapy for cancer as a treatment to reduce side effects caused by radiation toxicity and improve local tumor control.

Web Sitewww.aolsrx.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Aeolus Pharmaceuticals Inc Dividend Stock News and Updates

Dec. 13, 2018CLOSE PRICE DECREASE: Aeolus Pharmaceuticals Inc (OTCBB: AOLS) on 12-13-2018 decreased close price > 10% from $0.00 to $0.00

Read more...

Dec. 08, 2018CLOSE PRICE DECREASE: Aeolus Pharmaceuticals Inc (OTCBB: AOLS) on 12-08-2018 decreased close price > 10% from $0.00 to $0.00

Read more...

Dec. 07, 2018CLOSE PRICE INCREASE: Aeolus Pharmaceuticals Inc (OTCBB: AOLS) on 12-07-2018 increased close price > 10% from $0.00 to $0.00

Read more...
More Aeolus Pharmaceuticals Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Dec. 13, 2018CLOSE PRICE INCREASE: AXM Pharma Inc (OTCBB: AXMP) on 12-13-2018 increased close price > 10% from $0.00 to $0.00

Read more...

Dec. 13, 2018CLOSE PRICE DECREASE: Ampio Pharmaceuticals Inc (AMEX: AMPE) on 12-13-2018 decreased close price > 10% from $0.54 to $0.49

Read more...

Dec. 13, 2018CLOSE PRICE DECREASE: Aradigm Corp. (NASDAQ: ARDM) on 12-13-2018 decreased close price > 10% from $0.63 to $0.54

Read more...
More Pharmaceuticals Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor